The NMPA (National Medical Products Administration) Key Laboratory for Research and Evaluation of Innovative Drug focuses on key technical issues throughout the drug clinical research process. The laboratory cultivates and assembles top talent teams and establishes world-leading platforms in the field of new drug clinical research. It conducts research with innovative thinking and advanced technical methods to address critical clinical bottlenecks in new drug development. Setting sights on advancing new drug research, the laboratory actively promotes exchange and cooperation, leads the continuous development of China's clinical evaluation capabilities, supports national strategic needs, and provides strong technical support for China's new drug review and regulation.